Medical and Pharmaceutical AI-powered blood test promises lung cancer detection 5 years in advance British scientists used the biopsy to detect a 14-protein blood signature linked to the disease Rowan Dunne5 days ago
Medical and Pharmaceutical International research surge highlights asbestos health crisis It's being overlooked in lung cancer screening, causing a record number of legal claims and may be deadlier than once thought Rowan DunneJune 2, 2026
Medical and Pharmaceutical Novartis advances actinium-based cancer drug after promising trial data Researchers presented the findings at the annual meeting of the American Society of Clinical Oncology in Chicago Joseph MortonJune 1, 2026
Medical and Pharmaceutical Cuban lung cancer vaccine ‘VAXIRA’ pulls spotlight with innovation award Created in partnership with Argentine scientists, the injection gets the immune system to hunt lung cancer cells Rowan DunneJune 1, 2026
Medical and Pharmaceutical Cambridge researchers develop urine test that could detect lung cancer years earlier Scientists said the test may also monitor whether treatment works and detect signs of relapse before patients experience symptoms Joseph MortonMay 28, 2026
Medical and Pharmaceutical China’s Westlake University develops palm-sized lung cancer blood test It could surpass current liquid biopsy options after further evaluation Rowan DunneMay 27, 2026
Medical and Pharmaceutical Guardant gets FDA nod for next-gen cancer mutation blood test Milestone builds on firm attaining FDA Breakthrough Device Designation for another liquid biopsy in 2025 Rowan DunneMay 24, 2026
Medical and Pharmaceutical Susan Wojcicki Foundation unites tech and healthcare leaders against lung cancer The Troper and Wojcicki families committed USD$150 million to establish the organization Joseph MortonMay 19, 2026
Medical and Pharmaceutical University of Manitoba researchers develop dual-mode breast cancer imaging system The system uses wave imaging to look inside breast tissue Joseph MortonMay 7, 2026
Medical and Pharmaceutical CNS Pharma sees 250% spike from oversubscribed private placement The oncology and biotech firm has secured approximately US$22.5 million Rowan DunneMay 5, 2026